Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. The company focuses on addressing unmet demands in soft tissue restoration and regeneration, with a particular emphasis on tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company's technology, which includes microfluidic biofabrication and electrospinning, enables it to create advanced biomaterial-based devices that enhance healthcare providers' ability to repair and regenerate damaged soft tissue.
HAPPE Spine
Venture Round in 2021
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, that focuses on developing and commercializing innovative material technology for spinal implants. Incorporated in 2018, the company specializes in creating partial or fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants, which exhibit optimal mechanical properties suitable for orthopedic applications. HAPPE Spine's technology features interconnected porosity and enhanced surface textures that promote bone engagement and long-term fixation. Additionally, the implants possess bioactive properties that facilitate bone in-growth and on-growth, addressing various orthopedic challenges. Operating as a subsidiary of Genesis Innovation Group, LLC, HAPPE Spine aims to advance solutions in spinal fusion and orthopedic implant technology.
Virtual Incision
Series B in 2020
Virtual Incision is a medical technology company focused on developing innovative robotic-assisted surgical devices, specifically targeting colon resection. The company has created the MIRA (Miniaturized In vivo Robotic Assistant) Platform, which is a pioneering miniaturized surgical robotic support device. This platform allows for efficient operating room setups in minutes, eliminating the need for cumbersome equipment handling such as draping or docking. By enhancing the surgical process, Virtual Incision aims to improve clinical outcomes while also addressing healthcare costs, positioning itself as a leader in the field of robotic-assisted surgery.
Embody
Venture Round in 2019
Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. The company focuses on addressing unmet demands in soft tissue restoration and regeneration, with a particular emphasis on tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company's technology, which includes microfluidic biofabrication and electrospinning, enables it to create advanced biomaterial-based devices that enhance healthcare providers' ability to repair and regenerate damaged soft tissue.
Shoulder Innovations
Series A in 2018
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.
HAPPE Spine
Seed Round in 2018
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, that focuses on developing and commercializing innovative material technology for spinal implants. Incorporated in 2018, the company specializes in creating partial or fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants, which exhibit optimal mechanical properties suitable for orthopedic applications. HAPPE Spine's technology features interconnected porosity and enhanced surface textures that promote bone engagement and long-term fixation. Additionally, the implants possess bioactive properties that facilitate bone in-growth and on-growth, addressing various orthopedic challenges. Operating as a subsidiary of Genesis Innovation Group, LLC, HAPPE Spine aims to advance solutions in spinal fusion and orthopedic implant technology.
SafKan Health
Seed Round in 2018
SafKan Health, founded in 2016 and based in Tucson, Arizona, specializes in the development and manufacturing of automated ear cleaning devices for clinical applications. Its flagship product, OtoSet, is the first automated ear cleaning device to receive FDA clearance, addressing the needs of the 35 million Americans affected by impacted earwax, a common cause of conductive hearing loss. OtoSet offers a hygienic and mess-free solution for earwax removal, featuring disposable ear tips and waste containers. The device is designed to perform both bilateral and unilateral procedures, allowing for effective removal of mild to severe earwax impactions, thereby providing patients with a safe and efficient tool for ear care.
Shoulder Innovations
Series A in 2017
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.
Magnesium Development
Seed Round in 2016
Magnesium Development Company, LLC is a medical device development firm based in Grand Rapids, Michigan, founded in 2014. The company specializes in innovative medical devices utilizing a breakthrough magnesium alloy technology known as BioMg 250. This technology merges the desirable handling and strength characteristics of metal with the advantage of complete bioabsorption, addressing significant challenges in sports medicine orthopedics. Magnesium Development's products are designed to improve surgical outcomes for soft tissue injuries, such as those affecting the knee, shoulder, and lower extremities. By providing a resorbable solution, the company aims to mitigate issues like delayed resorption, mechanical failure, and complications related to traditional materials, ultimately supporting patients in their recovery and return to active lifestyles.